Avalanche, Investors Ask To Consolidate Stock Drop Suits
Avalanche Biotechnologies Inc. and a putative class of investors suing the company over a stock drop they claim were due to misrepresentations about a vision treatment's clinical trial design asked a...To view the full article, register now.
Already a subscriber? Click here to view full article